within Pharmacolibrary.Drugs.ATC.A;

model A02BC02_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.77,
    Cl             = 7.7 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,
    adminCount     = 1,
    Vd             = 0.013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.014666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Pantoprazole is a proton pump inhibitor (PPI) used for the treatment of gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and other acid-related disorders. It works by inhibiting the gastric H+/K+-ATPase enzyme, thereby reducing gastric acid secretion. It is approved for use in many countries and is available both as oral and intravenous formulations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following single oral dose of pantoprazole.</p><h4>References</h4><ol><li><p>Gawrońska-Szklarz, B, et al., &amp; Drozdzik, M (2012). CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers. <i>European journal of clinical pharmacology</i> 68(9) 1267–1274. DOI:<a href=&quot;https://doi.org/10.1007/s00228-012-1252-3&quot;>10.1007/s00228-012-1252-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22418828/&quot;>https://pubmed.ncbi.nlm.nih.gov/22418828</a></p></li><li><p>Poole, P (2001). Pantoprazole. <i>American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists</i> 58(11) 999–1008. DOI:<a href=&quot;https://doi.org/10.1093/ajhp/58.11.999&quot;>10.1093/ajhp/58.11.999</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11402494/&quot;>https://pubmed.ncbi.nlm.nih.gov/11402494</a></p></li><li><p>Huber, R, et al., &amp; Zech, K (1996). Pharmacokinetics of pantoprazole in man. <i>International journal of clinical pharmacology and therapeutics</i> 34(1 Suppl) S7–S16. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8793599/&quot;>https://pubmed.ncbi.nlm.nih.gov/8793599</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A02BC02_1;
